Mylan makes US$30 billion offer for Perrigo

8 April 2015 - Deborah Wilkes

Archived

Generics firm Mylan has offered to buy Perrigo in a cash and shares deal worth US$30.1 billion. The move comes just days after Perrigo completed the acquisition of Belgian OTC specialist Omega Pharma for €3.8 billion (US$4.2 billion) including the assumption of €1.3 billion in debt.

Click tags below for more information on topics:

Mylan

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: